We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$71.7M
Cap. Flow
+$61.6M
Cap. Flow %
16.74%
Top 10 Hldgs %
80.73%
Holding
256
New
50
Increased
99
Reduced
30
Closed
47

Sector Composition

Rank Sector Weight
1 Real Estate 18.83%
2 Healthcare 12.69%
3 Technology 1.7%
4 Industrials 0.97%
5 Financials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OYST
51
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$627K 0.17%
36,500
+14,500
+66% +$276K
MRSN
52
DELISTED
Mersana Therapeutics
MRSN
$618K 0.17%
1,820
+600
+49% +$227K
EFC
53
Ellington Financial
EFC
$1.7B
$613K 0.17%
+32,000
New +$591K
FUSN
54
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$578K 0.16%
71,500
+34,500
+93% +$297K
BCEL
55
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$567K 0.15%
66,500
+56,500
+565% +$579K
PMT
56
PennyMac Mortgage Investment
PMT
$863M
$564K 0.15%
+26,764
New +$535K
RBOT
57
DELISTED
Vicarious Surgical
RBOT
$548K 0.15%
+1,833
New +$546K
RWT
58
Redwood Trust
RWT
$641M
$545K 0.15%
+45,148
New +$504K
ADAM
59
Adamas Trust
ADAM
$807M
$528K 0.14%
+29,553
New +$538K
ARNA
60
DELISTED
Arena Pharmaceuticals Inc
ARNA
$512K 0.14%
7,500
+4,750
+173% +$310K
ADAP
61
DELISTED
Adaptimmune Therapeutics
ADAP
$511K 0.14%
120,000
+69,000
+135% +$335K
STRO icon
62
Sutro Biopharma
STRO
$391M
$502K 0.14%
2,700
+2,300
+575% +$450K
AHCO icon
63
AdaptHealth
AHCO
$1.49B
$493K 0.13%
+18,000
New +$513K
CWB icon
64
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.78B
$480K 0.13%
5,530
+616
+13% +$52.1K
REM icon
65
iShares Mortgage Real Estate ETF
REM
$559M
$468K 0.13%
12,599
-45
-0.4% -$1.65K
BKLN icon
66
Invesco Senior Loan ETF
BKLN
$7.19B
$465K 0.13%
20,993
+1,742
+9% +$38.6K
MTG icon
67
MGIC Investment
MTG
$6.23B
$459K 0.12%
+33,775
New +$485K
KNSA icon
68
Kiniksa Pharmaceuticals
KNSA
$4.92B
$453K 0.12%
32,500
+13,500
+71% +$205K
IMTX icon
69
Immatics
IMTX
$1.31B
$435K 0.12%
37,500
+3,500
+10% +$41.1K
PTCT icon
70
PTC Therapeutics
PTCT
$6.52B
$423K 0.11%
+10,000
New +$428K
MS icon
71
Morgan Stanley
MS
$339B
$405K 0.11%
4,413
+2,203
+100% +$189K
PBP icon
72
Invesco S&P 500 BuyWrite ETF
PBP
$348M
$398K 0.11%
17,565
+401
+2% +$8.83K
EMB icon
73
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.6B
$390K 0.11%
3,472
+543
+19% +$60.4K
EMHY icon
74
iShares JPMorgan EM High Yield Bond ETF
EMHY
$613M
$388K 0.11%
8,483
+591
+7% +$26.8K
DBTX
75
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$387K 0.11%
45,000
+36,000
+400% +$318K

Similar funds

AlphaCentric Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, AlphaCentric Advisors held 256 positions worth $368M, up 24% from $297M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

AlphaCentric Advisors deployed $61.6M of net new capital in Q2 2021, opening 50 new positions and adding to 99 existing holdings. Its largest new stake was Rithm Capital: 245,158 shares worth $2.6M.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Azenta, an estimated $485K trimmed.

  • AlphaCentric Advisors's largest Q2 2021 buy was Rithm Capital: 245,158 shares worth $2.6M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q2 2021, an estimated $24.9M increase.
  • AlphaCentric Advisors's biggest Q2 2021 reduction was Azenta, cutting an estimated $485K.
  • AlphaCentric Advisors fully exited Raven Industries Inc in Q2 2021, selling an estimated $1.53M.
  • AlphaCentric Advisors's ten largest holdings make up 81% of its $368M portfolio in Q2 2021.
  • AlphaCentric Advisors opened 50 new positions and closed 47 in Q2 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $368M.

Based on AlphaCentric Advisors's 13F filing for Q2 2021, filed 9 Mar 2022.